A Post-marketing Database Surveillance to Investigate the Risk of Hepatic Events in Hypercholesterolemic Patients Treated with ATOZET or Ezetimibe Atorvastatin coadministration in Japan (MK-0653C-853)

First published 15/06/2021

Last updated 23/04/2024

EU PAS number:

EUPAS41295

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

MK-0653C-853-00-v2-Prot_Final Redaction

English (1.46 MB - PDF)View document

Study results

Study results

MK0653C-853-CSR_final redaction

English (2.72 MB - PDF)View document

Study report

Other information